You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Ethyol Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Ethyol, and what generic alternatives are available?

Ethyol is a drug marketed by Clinigen and is included in one NDA.

The generic ingredient in ETHYOL is amifostine. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amifostine profile page.

Drug patent expirations by year for Ethyol
Drug Prices for Ethyol

See drug prices for Ethyol

Recent Clinical Trials for Ethyol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
M.D. Anderson Cancer CenterPhase 1
Children's Hospital Medical Center, CincinnatiPhase 2
AstraZenecaPhase 2

See all Ethyol clinical trials

Pharmacology for Ethyol
Paragraph IV (Patent) Challenges for ETHYOL
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ETHYOL For Injection amifostine 500 mg/vial 020221 1 2004-04-16

US Patents and Regulatory Information for Ethyol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Ethyol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 ⤷  Try a Trial ⤷  Try a Trial
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 ⤷  Try a Trial ⤷  Try a Trial
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 ⤷  Try a Trial ⤷  Try a Trial
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 ⤷  Try a Trial ⤷  Try a Trial
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 ⤷  Try a Trial ⤷  Try a Trial
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 ⤷  Try a Trial ⤷  Try a Trial
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for Ethyol

See the table below for patents covering Ethyol around the world.

Country Patent Number Title Estimated Expiration
Denmark 0655917 ⤷  Try a Trial
Japan 3503943 ⤷  Try a Trial
Hungary 9500277 ⤷  Try a Trial
Czech Republic 9500230 ⤷  Try a Trial
Australia 739068 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 9403179 ⤷  Try a Trial
Australia 1718499 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.